Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery (NOSH)
Status
Conditions
Treatments
Details and patient eligibility
About
In this pragmatic clinical trial, the investigators will study older Veterans approaching surgery for gastrointestinal or genitourinary cancer who are at high risk for a marked decline in their physical function. The investigators will test a multi-targeted nutrition regimen high in protein and other key nutrients and including resistance exercise, administered 8 weeks prior to surgery and for 24 weeks after discharge from surgery, with the goal of protecting physical function and improving physiologic, metabolic, and patient-centered outcomes. The findings of this study will promote a better intervention to compensate for the high nutritional demands of cancer and its treatment and lead to stronger, more rapid physical recoveries and better quality of life for older adults with moderate to advanced cancer-a group that has rarely been included in long-term nutrition studies. In addition to providing direct benefits to Veterans, the study may also benefit the VA by decreasing demands on the health care system via hastening the recovery of physical function.
Full description
The overall objective of this study is to administer the nutrition optimization of senior health (NOSH) intervention in biphasic intervals and compare it to a typically recommended nutrition regimen (Typical Regimen) for (1) physical function, (2) physiologic and metabolic outcomes; and (3) Veteran-centered outcomes. The central hypothesis is that NOSH will improve physical function. The investigators also predict improvements in physiologic, metabolic and Veteran-centered outcomes. The investigators seek an optimal intervention to alleviate symptom burden and improve function, health, and QoL for older cancer survivors, and the long-term goal is to confirm and implement this intervention. The primary aim is to evaluate the efficacy of a multi-targeted NOSH intervention on physical function. Based on preliminary data, the investigators' working hypothesis is that the NOSH intervention will result in improved physical function before surgery and after surgery relative to the (Typical Regimen).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Male and Female Veterans
- Stage I, II, III cancer of the bladder, colon, kidney, liver, pancreas, stomach or rectum
- Surgery 6 weeks from consent
- Age > 60 years
- Age-normal renal function
- English speaking
- Able to record dietary intake or has a proxy who can record dietary intake
- Willing and able to be randomized to either intervention group
Exclusion criteria
- Stage IV cancer diagnosis
- Glomerular filtration rates (GFR) less than 45 mL/min
- Neurological conditions causing functional impairments, including Parkinson's disease, multiple sclerosis, and permanent disability due to stroke
- Class III-IV congestive heart failure
- Refractory cachexia - medical condition that affects ability to increase muscle mass (e.g., cachexia) defined as 10% weight loss in 10 months, 5% weight loss in 6 months or 2% weight loss over any period plus body mass index 20 kg/m2 AND Life expectancy 9 months
- Active treatment for another cancer site
- Body weight >450 lbs
- Uncontrolled diabetes (HbA1c 9%)
- Recent diagnosis of thyroid disease or untreated thyroid disease
- Inability to complete physical function assessment
- Severe dietary restrictions
- On chemotherapy drug Sorafenib
Trial design
Primary purpose
Allocation
Interventional model
Masking
188 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Kathryn N Starr, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal